North Rock Partners, LLC Gsk PLC Transaction History

North Rock Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$42.05 - $47.77 $265,251 - $301,333	-6,308 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$40.23 - $47.74 $56,080 - $66,549	-1,394 Reduced 18.1%	6,308 $275,000
Q4 2021 Feb 07, 2022	BUY	$38.88 - $45.31 $299,453 - $348,977	7,702 New	7,702 $340,000
Q3 2021 Nov 12, 2021	SELL	$38.79 - $43.16 $195,462 - $217,483	-5,039 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$36.52 - $41.46 $184,024 - $208,916	5,039 New	5,039 $201,000

Q1 2020 May 13, 2020	SELL	$32.47 - $48.83 $543,125 - $816,779	-16,727 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$42.0 - $48.25 $7,266 - $8,347	173 Added 1.05%	16,727 $786,000
Q4 2019 Feb 12, 2020	BUY	$42.0 - $48.25 $695,268 - $798,730	16,554 New	16,554 $786,000
Q2 2019 Aug 12, 2019	SELL	$39.4 - $42.7 $201,964 - $218,880	-5,126 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$38.57 - $42.69 $197,709 - $218,828	5,126 New	5,126 $217,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $78.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on North Rock Partners, LLC with notifications on news.